Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - ACCOUNTS PAYABLE
Accounts Payable APLS - Apellis Pharmaceuticals, Inc.
37.5 M
LAST VALUE
48.95%
2 YEAR CAGR
29.62%
5 YEAR CAGR
59.42%
10 YEAR CAGR